📢 Resilience has chosen VGXI for the supply of pDNA, signaling a promising partnership in the biotech industry. 🤝 VGXI is a leading provider of high-quality plasmid DNA (pDNA) manufacturing. This collaboration will support the development of innovative biotech products. 💼 #Resilience #VGXI #biotech
📢 Resilience Teams Up with VGXI for Revolutionary Biotech Products
Introduction:
Resilience has selected VGXI as its supplier for plasmid DNA (pDNA) to support the development of its RNA-based COVID-19 and cancer therapeutic programs. This partnership will enable Resilience to access VGXI’s reliable and high-quality pDNA manufacturing services, ensuring the successful progression of its innovative therapies.
Main points:
- Resilience has chosen VGXI as its supplier for pDNA used in the development of RNA-based therapies for COVID-19 and cancer.
- This partnership will enable Resilience to access VGXI’s high-quality pDNA manufacturing services.
- VGXI has a proven track record of delivering exceptional quality and reliable pDNA to support gene therapy applications.
- The collaboration will ensure the efficient development and production of Resilience’s therapeutic programs.
- This partnership highlights the importance of reliable and high-quality pDNA manufacturing services in the advancement of innovative therapies.
Conclusion:
Resilience has selected VGXI as its supplier for pDNA to support the development of its RNA-based therapies for COVID-19 and cancer. This collaboration will ensure the efficient and successful progression of Resilience’s therapeutic programs, highlighting the significance of reliable and high-quality pDNA manufacturing services in the advancement of innovative therapies.
